Milestone Pharmaceuticals Reports Q3 2026 Results, Extends Cash Runway Into Late 2028

Milestone Pharmaceuticals reported third-quarter 2026 product revenue of $963,000 and a net loss of $25.8 million, compared with no product revenue and a $11.9 million net loss a year earlier. The company said it expects to reduce operating expenses by approximately 30% and extend its cash runway i…